---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-024213"
form_type: "8-K/A"
ticker: null
cik: "0000859737"
company_name: "HOLOGIC INC"
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:36:52.690386+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Hologic Q2 beats: revenue $1,018M, adj EPS $1.03; raises FY24 guidance; acquires Endomagnetics for $310M

## Summary
- Q2 revenue $1,017.8M (down 0.8% YoY) exceeded guidance; GAAP diluted EPS $0.72, non-GAAP $1.03.
- Organic revenue ex-COVID grew 4.9% constant currency; Diagnostics ex-COVID +9.8%, Surgical +7.4%.
- Company raised full-year revenue midpoint in constant currency and EPS guidance on strong margins.
- Agreed to acquire Endomagnetics Ltd for ~$310M, adding breast cancer surgery technologies.
- Cash flow from operations $292.4M; cash generation remains strong.

## SEC filing metadata
- accession: 0001140361-24-024213
- form_type: 8-K/A
- cik: 0000859737
- company_name: HOLOGIC INC
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/859737/000114036124024213/0001140361-24-024213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/859737/000114036124024213/ef20028431_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-024213
- JSON: https://secwatch.observer/filing/0001140361-24-024213.json
- Plain text: https://secwatch.observer/filing/0001140361-24-024213.txt

## Key facts
- Earnings Releases
  HOLOGIC INC reported the second quarter ended March 30, 2024 results: revenue $1,017.8 million, EPS $0.72. Guidance raised.
  - Period: the second quarter ended March 30, 2024
  - Revenue: $1,017.8 million
  - EPS: $0.72
  - Guidance: raised
  - Result: reported results
  source text: Hologic Announces Financial Results for Second Quarter of Fiscal 2024 – Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comparable – – Company Raises Full-Year Revenue Midpoint in Constant Currency and Raises EPS Guidance on Strong Margins
  evidence_url: https://www.sec.gov/Archives/edgar/data/859737/000114036124024213/0001140361-24-024213-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.